Endoleak Type II management with InterlockTM
Intra-operative coil embolisation improves EVAR results for high risk patients
Persistent Endoleak Type II (EL II) is not a rare complication and it could require re-interventions.1 It has been shown that 10 - 26% of patients develop an Endoleak Type II after EVAR with reported reintervention rate of 19% -26%2,3
Treating patient with predictive factors to develop a persistent Endoleak Type II after EVAR results in fewer EL II incidence rates and reduced re-interventions during early and midterm follow-up. 4,5
The efficacy, safety and reproducibility of intra-operative coil embolization of the aneurysmal sac during EVAR for patients at risk for Type II Endoleak, with no immediate or short-term major complications have been demonstrated4,5